These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Time to first recurrence as a trial endpoint: time to change? Mehra R Card Electrophysiol Rev; 2003 Sep; 7(3):280-4. PubMed ID: 14739728 [TBL] [Abstract][Full Text] [Related]
3. Rhythm control in atrial fibrillation: endpoints for device-based trials. Gillis AM Heart Rhythm; 2004 Jul; 1(2 Suppl):B52-7, discussion B57. PubMed ID: 15851140 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic burden as an endpoint to evaluate interventions in patients with atrial fibrillation. Darbar D; Roden DM Heart Rhythm; 2005 May; 2(5):544-9. PubMed ID: 15840484 [TBL] [Abstract][Full Text] [Related]
6. Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial. Euler DE; Friedman PA Card Electrophysiol Rev; 2003 Dec; 7(4):355-8. PubMed ID: 15071253 [TBL] [Abstract][Full Text] [Related]
7. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation. Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026 [TBL] [Abstract][Full Text] [Related]
8. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. Gillis AM; Koehler J; Morck M; Mehra R; Hettrick DA Heart Rhythm; 2005 Aug; 2(8):791-6. PubMed ID: 16051111 [TBL] [Abstract][Full Text] [Related]
9. Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience. Wyse DG; Slee A; Epstein AE; Gersh BJ; Rocco T; Vidaillet H; Volgman A; Weiss R; Shemanski L; Greene HL; Heart Rhythm; 2004 Nov; 1(5):531-7. PubMed ID: 15851214 [TBL] [Abstract][Full Text] [Related]
10. Are there alternatives to mortality as an endpoint in clinical trials of atrial fibrillation? Wyse DG Heart Rhythm; 2004 Jul; 1(2 Suppl):B41-4, discussion B44. PubMed ID: 15851138 [TBL] [Abstract][Full Text] [Related]
11. Monitoring of atrial fibrillation burden after surgical ablation: relevancy of end-point criteria after radiofrequency ablation treatment of patients with lone atrial fibrillation. Beukema R; Beukema WP; Sie HT; Misier AR; Delnoy PP; Elvan A Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):956-9. PubMed ID: 19762419 [TBL] [Abstract][Full Text] [Related]
12. [Atrial defibrillator]. Jung W; Lüderitz B Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804 [TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all. Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic information in implantable devices that pertain to endpoints in atrial fibrillation studies. Mehra R; Ziegler P; Koehler J Heart Rhythm; 2004 Jul; 1(2 Suppl):B64-9, discussion B69. PubMed ID: 15851142 [TBL] [Abstract][Full Text] [Related]
15. Relation of obesity to recurrence rate and burden of atrial fibrillation. Guglin M; Maradia K; Chen R; Curtis AB Am J Cardiol; 2011 Feb; 107(4):579-82. PubMed ID: 21195377 [TBL] [Abstract][Full Text] [Related]
16. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Kirchhof P; Auricchio A; Bax J; Crijns H; Camm J; Diener HC; Goette A; Hindricks G; Hohnloser S; Kappenberger L; Kuck KH; Lip GY; Olsson B; Meinertz T; Priori S; Ravens U; Steinbeck G; Svernhage E; Tijssen J; Vincent A; Breithardt G Europace; 2007 Nov; 9(11):1006-23. PubMed ID: 17897925 [TBL] [Abstract][Full Text] [Related]
17. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Afzal MR; Kanmanthareddy A; Earnest M; Reddy M; Atkins D; Bommana S; Bartus K; Rasekh A; Han F; Badhwar N; Cheng J; Dibiase L; Ellis CR; Dawn B; Natale A; Lee RJ; Lakkireddy D Heart Rhythm; 2015 Jan; 12(1):52-9. PubMed ID: 25281005 [TBL] [Abstract][Full Text] [Related]
18. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation. Gersak B; Pernat A; Robic B; Sinkovec M J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1059-66. PubMed ID: 22587585 [TBL] [Abstract][Full Text] [Related]